James Dennis O'toole, MD | |
5200 Centre Ave, Ste 703, Pittsburgh, PA 15232-1327 | |
(412) 687-8300 | |
(412) 687-8391 |
Full Name | James Dennis O'toole |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 5200 Centre Ave, Pittsburgh, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043214463 | NPI | - | NPPES |
0007965470004 | Medicaid | PA | |
0178211000 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MD012868E (Pennsylvania) | Primary |
207RC0000X | Internal Medicine - Cardiovascular Disease | 30568 (Missouri) | Secondary |
Mailing Address | Practice Location Address |
---|---|
James Dennis O'toole, MD 5200 Centre Ave, Ste 703, Pittsburgh, PA 15232-1327 Ph: (412) 687-8300 | James Dennis O'toole, MD 5200 Centre Ave, Ste 703, Pittsburgh, PA 15232-1327 Ph: (412) 687-8300 |
News Archive
On Monday, the Supreme Court will begin an extraordinary three-day hearing on the constitutionality of ObamaCare. At stake are the Constitution's structural guarantees of individual liberty, which limit governmental power and ensure political accountability by dividing that power between federal and state authorities. Upholding ObamaCare would destroy this dual-sovereignty system, the most distinctive feature of American constitutionalism.
The Associated Press/Seattle Times reports on a "mysterious epidemic that is devastating the Pacific Coast of Central America, killing more than 24,000 people in El Salvador and Nicaragua since 2000 and striking thousands of others with chronic kidney disease at rates unseen virtually anywhere else."
Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, today announced that it has resubmitted to the U.S. Food and Drug Administration the New Drug Application ("NDA") for its investigational candidate, YOSPRALA (PA32540/PA8140) for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.
A recent study demonstrated that two commercially available surface disinfectant formulations and one hand disinfection formulation that claim "virucidal activity against enveloped viruses" are effective in inactivating the SARS-CoV-2 virus. Their study has been published on the preprint server bioRxiv.
› Verified 6 days ago
Krishna Kancharla, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5200 Centre Ave, Suite 710, Pittsburgh, PA 15232 Phone: 412-623-6889 | |
Christine Peoples, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 5th Ave, Suite 3b Falk Medical Building, Pittsburgh, PA 15213 Phone: 412-647-6700 | |
Rima Abdel Massih, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3601 5th Ave, Suite 3a, Pittsburgh, PA 15213 Phone: 412-648-6273 | |
Dr. Matthew Michael Lander, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-6500 | |
Allie Dakroub, MD MS Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Lothrop Street, Suite 9 South, Pittsburgh, PA 15213 Phone: 412-692-4888 | |
Katrina Han, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 5th Ave Bldg Suite3a, Pittsburgh, PA 15213 Phone: 412-586-9700 | |
Omar Khaled Osman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1307 Federal St Ste B300, Pittsburgh, PA 15212 Phone: 412-359-3751 |